Anjali Singh

Tata Motors secures orders for over 5,000 buses from state transport bodies

Tata Motors has secured cumulative orders for over 5,000 buses and chassis from multiple state transport undertakings through government e-bidding, reinforcing its presence in public transport

CARS24 acquires Vehicle Info to build full-stack vehicle ownership platform

Acquisition of automotive utility app Vehicle Info will help CARS24 expand beyond buying and selling vehicles to build a platform offering services across the entire ownership lifecycle

West Asia crisis may hit Indian tyre industry; ATMA seeks policy support

Tyre makers warn that the West Asia conflict may disrupt exports, raise crude-linked input costs and strain supply chains, prompting ATMA to seek urgent policy support

Gas supply jitters begin rattling industry pockets across key sectors

LPG and natural gas shortages are beginning to disrupt parts of Indian industry, though most sectors say production remains largely stable for now

India, Uzbekistan launch pharma-nutra corridor; focus on Eurasian market

India and Uzbekistan have launched a policy-backed pharma-nutraceutical corridor to improve regulatory alignment, investment and market access for manufacturers targeting the $7-10 billion Eurasian he

Indian CDMOs expand capacity as demand for complex drug work rises

Indian CDMOs are expanding manufacturing capacity and investing in advanced technologies as global pharma companies increasingly outsource complex drug development and manufacturing work

Motilal Oswal buys 1.65% stake in Zelio E-Mobility for ₹9.8 crore

Motilal Oswal Financial Services has purchased a 1.65 per cent stake in Zelio E-Mobility through a Rs 9.8 crore block deal, boosting institutional interest in the newly listed EV maker

M&M: No official word from Indonesia on any suspension of vehicle orders

Mahindra said it has received no intimation from Indonesian authorities about suspending its vehicle imports, clarifying a media report and reaffirming its 35,000-unit export order

Aurobindo arm launches Pomalidomide generic in US, adds to oncology line

Aurobindo Pharma subsidiary Eugia Pharma has launched generic Pomalidomide Capsules in the US, one of the first-to-file applicants for the drug, expanding its oncology portfolio

Mercedes-Benz turns to localisation to lower luxury vans' entry price

Mercedes-Benz has localised assembly of V-Class in India, bringing its entry price to ₹1.4 cr, reducing dependence on costly imports, as the company repositions the van within its top-end portfolio

Cipla, Kemwell form biologics JV to tap fast-growing biosimilars market

Cipla will hold 60% in the new JV with Kemwell Biopharma, aiming to develop, manufacture and commercialise biologics and biosimilars for global markets amid rising demand

Volvo Car India drops 2030 electric-only target, recalibrates EV roadmap

The carmaker has shifted to a market-led EV strategy without fixed timelines, even as electric vehicles account for 25 per cent of its India sales and new models are planned for 2026

TVS Mobility, Palfinger to jointly set up ₹350 crore manufacturing plant

Austrian lifting solutions major Palfinger partners with TVS Mobility Group, investing €30 million to build a Pune plant and engineering hub, boosting localisation, exports and service reach in India

US tariff uncertainty: Auto, medtech exporters on wait-and-watch mode

Indian auto and medical device exporters adopt wait-and-watch approach as US tariff shifts and refund uncertainty cloud shipment decisions

Miltenyi Biotec weighs local CGT manufacturing, eyes export potential

German biotech firm explores hospital-linked cell and gene therapy manufacturing in India while assessing long-term opportunities in regional CGT production, training and exports

EPAM repositions India as co-innovation hub for life sciences, healthcare

EPAM bets on India as global co-innovation hub for AI-driven life sciences and healthcare expansion

Global pharma uses AI to speed drug timelines, but adoption remains uneven

Pharma leaders at BioAsia said AI is accelerating discovery and documentation, doubling pipelines at some firms, though its impact on clinical costs and timelines remains uneven

Hyderabad strengthens role as MNC hub for AI, life sciences and GCC growth

Global firms are scaling AI, life sciences and GCC operations in Hyderabad, backed by strong talent, pharma depth and policy support, with major investments announced around BioAsia this week

Sanofi scales up Hyd hub, cements India's role in global pharma GCC play

Sanofi has expanded its Hyderabad Global Capability Centre, raising capacity to 4,500 employees and strengthening India's position as a key hub for R&D, AI, digital innovation

Two-wheeler makers see split export recovery in October-December quarter

Market-specific recovery patterns drove swings in overseas volumes in Q3